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Infectious Bursal Disease Virus (IBDV) is a constant threat to the poultry 
industry worldwide. This virus encodes a non-structural protein VP5 (17 kDa) 
that is capable of inducing apoptosis and may play an important role in 
pathogenesis of IBD. The nucleoprotein (NP) of Newcastle Disease Virus 
(NDV) has been shown possible to be use as a general carrier. In this study, 
the C-terminal end of NP full-length (pTrcHis2) were fused to the full-length of 
VP5  of IBDV to study the effect of these construct in cell culture and the 
possibility of this recombinant to induce apoptosis. The clones were then 
expressed and solubility test were done to determine the level of solubility of 
the recombinant proteins by Western blot.  The DNA insert of NPfl-VP5 and 
VP5 were further subcloned into pCDNA3.1/V5 TOPO TA vector. The 
pcDNA3.1-NPfl-VP5 and pcDNA3.1-VP5 constructs were tested for transient 
expression in Chinese hamster ovary (CHO) cells. DNA laddering analysis 
and Acridine orange propidium iodide (AOPI) was also performed in order to 
check for any changes due to apoptosis.  Expression of the NPfl-VP5 protein 
in E. coli was not detected by SDS-PAGE but a band at the expected size (~ 
iii 
 
70-80 kDa) was detected using Western. Only 5% of this protein was soluble. 
The PCR products of NPfl-VP5 (1.9 kb) and VP5 (447 bp) were subcloned 
into pcDNA3.1 vector.  The CHO cells that were used in in vitro expression 
were successfully transfected with the plasmid contain the inserts. After 48 
hours post-transfection, the cells that were transfected with pcDNA3.1-NPfl-
VP5 and pcDNA3.1-VP5 plasmids exhibited apoptosis. In contrast, no 
apoptosis was observed in the cells transfected with pcDNA3.1 vector only. 
To confirm that apoptosis had occurred, at 48 hours post-transfection, the 
cellular DNA was extracted and analyzed by 2% agarose gel electrophoresis. 
A laddering effect indicative of nucleosomal fragmentation, was detected in 
the DNA samples obtained from the cells transfected with pcDNA3.1-
NPflVP5 or with pcDNA3.1-VP5 but not with the samples from cells 
transfected with pcDNA3.1 vector only. The expression of NPfl-VP5 and VP5 
proteins in transfected CHO cells were detected by Western blot analysis 
using anti-V5, anti-NDV, anti-IBDV and anti-VP5 antibodies. Further 
investigation using AOPI methods also confirm the apoptosis effects. 
Statistical analysis showed that the percentage of apoptosis cells was 
significantly higher when transfected with pcDNA3.1-NPflVP5 compare with 
pcDNA3.1-VP5. As a conclusion, the recombinant protein was successfully 
constructed and NP can be used as a carrier, and the fusion of NP to VP5 
will induce more apoptosis. However, it just slightly increases its solubility. 
Thus, the results showed that recombinant protein NPfl-VP5 and also VP5 
alone were able to induce apoptosis in cell culture. 
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Virus penyakit bursa berjangkit (IBDV) merupakan ancaman yang berterusan 
kepada industri ternakan ayam seluruh dunia. Virus ini mempunyai protein 
yang tidak berstruktur VP5 (17 kDa) yang mampu untuk meransang 
apoptosis dan mungkin memainkan peranan penting didalam proses 
patogenesis IBD. Nukleoprotein (NP) Virus Penyakit Newcastle (NDV) telah 
dikatakan berkemungkinan berguna sebagai pembawa umum. Oleh itu, 
didalam kajian ini, hujung terminal-C NP (pTrcHis2) telah digabungkan 
dengan VP5 penuh untuk mengkaji kesan penggabungan ini didalam kultur 
sel dan kemungkinan gabungan ini untuk meransang apoptosis. Klon-klon ini 
telah diekspreskan dan ujian kelarutan telah dilakukan untuk menentukan 
tahap kelarutan protein rekombinan dengan Western blot. Seterusnya NPfl-
VP5 dan VP5 telah disubklon ke dalam vector pCDNA3.1/V5 TOPO TA yang  
kemudiannya telah di uji untuk pengekspresan ‘transient’ didalam sel 
Chinese hamster ovary (CHO). Analisis ‘DNA Laddering’ dan ‘Acridine 
orange propidium iodide’ (AOPI) juga telah dijalankan untuk meneliti 
sebarang perubahan yang disebabkan oleh apoptosis. Pengekspresan 
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protein NPfl-VP5 didalam E. coli tidak dapat dikesan menggunakan SDS-
PAGE tetapi jalur saiz yang dijangka (70 ke 80 kDa) telah dikesan dengan 
menggunakan Western blot. Hanya 5% daripada protein larut. Produk PCR 
NPfl-VP5 (1.9 kb) dan VP5 (447 kb) telah disubklon ke dalam vector 
pcDNA3.1. Selepas 48 jam setelah sel CHO ditransfeksi secara in-vitro, sel-
sel yang ditransfekkan dengan plasmid pcDNA3.1-NPfl-VP5 dan pcDNA3.1-
VP5 menunjukkan apoptosis. Sebaliknya, tiada apoptosis dilihat didalam sel-
sel yang ditransfekkan dengan kawalan. Untuk memastikan yang apoptosis 
telah berlaku pada 48 jam selepas transfeksi, DNA selular telah diekstrak 
dan dianalisa menggunakan 2% gel agarose elektroforesis. Kesan 
“bertangga” menandakan pemecahan nukleosomal telah dikesan didalam 
sampel DNA yang didapati dari sel-sel yang ditransfekkan dengan 
pcDNA3.1-NPflVP5 atau dengan pcDNA3.1-VP5 tetapi tidak dengan sampel 
dari sel-sel yang ditransfekkan dengan kawalan. Pengekspresan protein 
NPfl-VP5 dan VP5 didalam sel-sel CHO yang ditransfekkan telah dikesan 
menggunakan analisa Western blot menggunakan antibodi anti-V5,anti-
NDV,anti-IBDV dan anti-VP5. Kajian AOPI juga mengesahkan kesan 
apoptosis. Analisis statistik telah menunjukkan bahawa peratus sel apoptosis 
secara signifikan adalah lebih tinggi bila ditransfekkan dengan pcDNA3.1-
NPfl-VP5 berbanding pcDNA3.1-VP5. Sebagai kesimpulan, protein 
gabungan telah berjaya dibentuk dan diekspreskan, dan gabungan NP dan 
VP5 akan lebih merangsang apoptosis.  NP boleh digunakan sebagai 
pembawa walaupun hanya meningkatkan sedikit kelarutannya. Keputusan 
juga menunjukkan yang protein recombinan NPfl-VP5 dan juga VP5 mampu 
untuk meransang apoptosis didalam kultur sel.  
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CHAPTER 1 
 
INTRODUCTION 
 
Infectious bursal disease virus (IBDV) is a major important pathogen to the 
poultry industry worldwide, causing a highly contagious immunosuppressive 
disease in young chickens by destroying the lymphoid cells in the bursa of 
Fabricius (BF) (Mundt et al.,1995). In addition, the immunosuppression 
increases the susceptibility of these chickens to other infections and 
interferes with vaccination against other diseases (Saif,1991).   
 
IBDV is a small, icosahedral and non-enveloped virus which belongs to the 
genus Avibirnavirus of the family Birnaviridae (Murphy et al., 1995). There 
are two serotypes of IBDV; serotype 1 strains are pathogenic to chickens 
whereas serotype 2 strains are not (Ismail et al., 1988).  The virus contains a 
bisegmented double-stranded RNA genome, namely segments A and B.  
The larger Segment A encodes three structural virion proteins, VP2, VP3 and 
VP4, and a nonstructural protein, VP5 (Mundt et al., 1997).  The smaller 
segment B, encodes VP1, the viral RNA polymerase (Muller & Nitschke, 
1987). VP2 has been identified as the host protective antigen as it contains 
the antigenic regions responsible for the induction of neutralizing antibodies 
(Fahey et al., 1989). VP3 is considered to be a group specific antigen as it is 
only recognized by  non-neutralizing antibodies, some of which cross-react 
with serotypes 1 and 2 (Oppling et al., 1991). VP4 is a viral protease involved 
in the processing of the polyprotein (Azad et al., 1987). It has been 
demonstrated that VP5 is neither required for the viral replication in vitro 
(Mundt et al., 1997) nor in vivo but plays an important role in pathogenesis as 
proven by the generation of a VP5-defective virus which had lost ability to 
cause bursal lesions (Yao et al., 1998).   
 
The use of a reverse genetics system has allowed the generation of a VP5 
knockout mutant.  Work with this VP5 deletion mutant has shown that VP5 is 
dispensable for virus replication in vitro (Mundt et al., 1997).  Interestingly,  
this mutant showed a highly attenuated phenotype which did not cause 
bursal lesions after experimental infection of susceptible chickens, 
demonstrating that VP5 plays a key role in IBDV pathogenesis and 
dissemination (Yao et al.,1998).  Consequently, VP5 has attracted attention 
as a potential target in the development of strategies to control IBDV. The 
study by Yao et al. (1998) indicated that the absence of VP5 protein 
expression in the mutant virus will not affect the humoral immune response to 
IBDV in the natural host.  Therefore, it may be feasible to develop a novel, 
live-attenuated vaccines for IBDV that are non-pathogenic to chickens.   
Although several   improvements in the control of the diseases by vaccination 
have been obtained, the results remain unsatisfactory. Despite strong 
interest in VP5, the Birnavirus life cycle has not been characterized in detail.  
Very little is known on the virus entry, genome transcription and replication,  
morphogenesis, and release of the viral progeny. 
 
Studies have shown that immunosuppresssion induced by IBDV is caused, at 
least in part, by apoptosis or programmed cell death (Tanimura & Sharma, 
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1998). Recently, it has been shown that an IBDV infection induces apoptosis 
in chicken embryo and tissue culture cells (Yao and Vakharia, 2001).  VP5 
alone is capable of inducing apoptosis in cell culture.  Transfection of chicken 
B-lymphocyte cell line (RP9) and chicken embryo fibroblast cells with a 
plasmid DNA containing the VP5 gene under the control of the intermediate-
early promoter enhancer region of human cytomegalovirus, induced 
apoptosis in both cell lines. Apoptotic changes such as chromatin 
condensation, DNA fragmentation, and the appearance of apoptotic nuclear 
bodies were observed in cell cultures 48-h post-transfection (Yao and 
Vakharia, 2001).  In addition, induction of VP5 expression also resulted in the 
alteration of cell morphology, the disruption of the plasma membrane, and a 
drastic reduction of cell viability. These observations indicate that the VP5 is 
highly cytotoxic and is involved in the release of the viral progeny from cells, 
an important role in viral pathogenesis. (Lombardo et al., 2000; Yao and 
Vakharia., 2001).  
 
The nucleoprotein (NP) of Newcastle disease virus (NDV) has recently been 
expressed in Escherichia coli where it assembles into ring-like particles. It 
has been suggested that the NP has the potential to be developed as a 
carrier for chimeric antigens (Kho et al, 2001b). In addition, it can be 
expressed in abundance as a highly soluble protein. This protein is stable 
and has its C-terminus exposed making it ideal for carrying any antigen or 
multiple antigens (Rabu et al, 2002). Therefore, it would be interesting to 
know whether the fusion of NP with VP5 might increase the efficacy of the 
latter in inducing apoptosis compared to VP5 alone, since fusion of NP with 
 3
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HN and F proteins of NDV  induced significant levels of antibodies against 
NDV in chickens (Rabu et al., 2002). With the use of NP as a carrier, NP-VP5 
might be expressed in soluble and stable form due to the ability of NP, which 
can act as a carrier for other peptide (Rabu et al., 2001). 
 
Despite a number of studies on IBDV, very little is known about the 
expression of the VP5 gene of IBDV or on a recombinant VP5. In this study, 
the full length of VP5 were fused to the C-terminal of NP to study the role and 
effect of chimera NP-VP5 and a possibility of this chimera could induce 
apoptosis. Hence, the purpose of fusing NP of NDV with VP5 of IBDV in this 
study was to increase the efficacy of VP5 in inducing apoptosis in normal 
mammalian cells.  
 
Therefore the objectives of this study are: 
1. to construct recombinant DNA molecules carrying NP of NDV and VP5 
gene of IBDV; 
2. to express the chimeric protein in a mammalian expression system; and 
to study its effect on apoptosis in vitro. 
CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 IBDV and the disease 
 
Infectious bursal disease (IBD) is a highly contagious, immunosuppressive 
disease of young chickens caused by the infectious bursal disease virus 
(IBDV). The disease is characterized by destruction of the lymphoid cells in 
the bursa of Fabricius (BF), which leads to severe B-cell suppression (Becht, 
1980; Kibenge et al., 1988) resulting in susceptibility to other infections and 
interferences with vaccination programmes (McFerran et al., 1980; Snyder et 
al., 1988). The infection depends on the dose and virulence of the strain, the 
age and breed of animals, and the presence or absence of passive immunity 
(Tacken et al., 2000). Nevertheless, the disease has no direct impact on 
public health as there is no evidence of transmission of IBDV to other non-
avian species including human.  
 
2.2 History and epidemiology  
 
The disease was discovered in 1962 in Gumboro, Delaware, USA (Cosgrove, 
1962) but had been present since 1957 (Cover, 1960). Later outbreaks were 
subsequently referred to as ‘Gumboro Disease’ after the geographic location. 
Originally the condition was named ‘nephritis-nephrosis syndrome of chicken’ 
because of prominent kidney lesions. After it became evident that an 
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